Lewis H. Bender's most recent trade in Intensity Therapeutics Inc was a trade of 37,749 Common Stock, $0.0001 Par Value done at an average price of $6.1 . Disclosure was reported to the exchange on March 26, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Intensity Therapeutics Inc | Lewis H. Bender | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 6.11 per share. | 26 Mar 2026 | 37,749 | 118,549 | - | 6.1 | 230,646 | Common Stock, $0.0001 Par Value |
| Intensity Therapeutics Inc | Lewis H. Bender | Director, President and CEO, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 May 2025 | 700,000 | 700,000 | - | - | Stock Option (right to buy Common Stock) | |
| Intensity Therapeutics Inc | Lewis H. Bender | Director, President and CEO, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2024 | 464,805 | 464,805 | - | - | Stock Option (right to buy Common Stock) | |
| Intensity Therapeutics Inc | Lewis H. Bender | Director, President and CEO, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2024 | 33,574 | 33,574 | - | - | Stock Option (right to buy Common Stock) |